Chengyuan Tang Selected Research

human GJB3 protein

11/2015	Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism.
1/2012	Pathogenic connexin-31 forms constitutively active hemichannels to promote necrotic cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chengyuan Tang Research Topics

Disease

12	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 01/2014
12	Fibrosis (Cirrhosis) 01/2022 - 01/2019
5	Chronic Renal Insufficiency 01/2022 - 01/2018
5	Neoplasms (Cancer) 01/2021 - 12/2015
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 01/2017
4	IGA Glomerulonephritis (IGA Nephropathy) 09/2022 - 01/2015
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2009
3	Sepsis (Septicemia) 12/2020 - 01/2014
3	Kidney Diseases (Kidney Disease) 01/2020 - 11/2016
2	Ureteral Obstruction 11/2020 - 10/2019
2	Ischemia 12/2019 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 04/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2018 - 01/2017
2	Proteinuria 01/2017 - 01/2015
2	Erythrokeratodermia Variabilis 11/2015 - 01/2012
1	Wounds and Injuries (Trauma) 11/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Rupture 01/2022
1	Atherosclerosis 01/2021
1	Cri-du-Chat Syndrome (5p- Syndrome) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Urethral Obstruction 01/2019
1	Reperfusion Injury 10/2018
1	Vascular Calcification 01/2018
1	Anemia 04/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2016
1	Obesity 11/2016
1	Cardio-Renal Syndrome 07/2016
1	Skin Diseases (Skin Disease) 11/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Fragile X Tremor Ataxia Syndrome 01/2013

Drug/Important Bio-Agent (IBA)

11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2015
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
4	Biological ProductsIBA 11/2022 - 01/2018
3	CreatinineIBA 01/2022 - 01/2015
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2017
3	LipidsIBA 01/2021 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2020
3	Oxygen (Dioxygen)IBA 12/2019 - 04/2017
2	triptolideIBA 09/2022 - 01/2015
2	CytokinesIBA 01/2022 - 12/2019
2	Long Noncoding RNAIBA 01/2021 - 10/2019
2	norcantharidinIBA 01/2021 - 11/2020
2	CateninsIBA 06/2020 - 01/2020
2	aristolochic acid I (aristolochic acid)IBA 01/2020 - 10/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2019 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 01/2017 - 01/2013
2	AntioxidantsIBA 01/2017 - 01/2014
2	PTEN-induced putative kinaseIBA 10/2016 - 03/2009
2	human GJB3 proteinIBA 11/2015 - 01/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2022
1	p38 Mitogen-Activated Protein KinasesIBA 09/2022
1	Chloroquine (Aralen)FDA LinkGeneric 01/2022
1	3-methyladenineIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2020
1	trans-4-hydroxy-L-prolineIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 10/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	DisulfidesIBA 01/2019
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Vitamin B Complex (B Vitamins)IBA 01/2019
1	Diphtheria ToxinIBA 10/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	ThioredoxinsIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	AntibodiesIBA 01/2018
1	mitoquinoneIBA 01/2017
1	Phosphotransferases (Kinase)IBA 12/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2016
1	fibroblast growth factor 21IBA 07/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 04/2015
1	Poly I-CIBA 01/2015
1	polymeric IgAIBA 01/2015
1	Immunoglobulin IsotypesIBA 01/2015
1	Immunoglobulin A (IgA)IBA 01/2015
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2015
1	mangiferinIBA 01/2014
1	InflammasomesIBA 01/2014
1	TOR Serine-Threonine KinasesIBA 01/2013
1	5' Untranslated Regions (5' UTR)IBA 01/2013

Therapy/Procedure

5	Therapeutics 11/2022 - 11/2016
3	Drug Therapy (Chemotherapy) 12/2019 - 12/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020
1	Punctures 01/2020
1	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 01/2020
1	Ligation 01/2020
1	Nephrectomy 10/2018